LAUSR

Sweet syndrome are relevant differential diagnoses in this scenario. First-line treatment of rosacea fulminans includes the combination of isotretinoin and corticosteroids, the latter exceptionally used for rosacea management. The exact duration and cumulative doses necessary for isotretinoin in this case are not clear, but some reports suggest that using daily doses ranging from 0.2 to 1.0 mg/kg, with 0.5 mg/kg/day as the most common dose for 6 months, could be appropriate. To conclude, the intensity of rosacea fulminans symptoms can be alarming to patients, affecting their quality of life. Dermatologists must perform early recognition of the condition and be aware that topical metronidazole might be a rare potential trigger.